Glucosamine and chondroitin may lower chances for chronic disease
To test the effect of glucosamine and chondroitin on chronic inflammation, doctors gave 18 healthy but overweight men and women a placebo or 1,500 mg of glucosamine hydrochloride plus 1,200 mg of chondroitin sulfate per day. The study had two 28-day phases, where each group took the placebo or glucosamine and chondroitin, and then switched for the second 28-day phase.

While there were no changes during the placebo phases, during the glucosamine and chondroitin phases, CRP levels declined by an average of 23 percent. Doctors said that the results are consistent with earlier studies that found a link between glucosamine and chondroitin and circulating levels of CRP, but that a major strength of this study is that participants were healthy and free of any underlying conditions that might have affected the results.

Reference: PLoS One; 2015, Vol. 10, No. 2, e0117534.
Previous Next Back to Top
More Related Articles